Publication: Pharmacokinetics of amodiaquine and desethylamodiaquine in pregnant and postpartum women with Plasmodium vivax malaria
Issued Date
2011-09-01
Resource Type
ISSN
10986596
00664804
00664804
Other identifier(s)
2-s2.0-80051804195
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Antimicrobial Agents and Chemotherapy. Vol.55, No.9 (2011), 4338-4342
Suggested Citation
Marcus J. Rijken, Rose McGready, Vincent Jullien, Joel Tarning, Niklas Lindegardh, Aung Pyae Phyo, Aye Kyi Win, Poe Hsi, Mireille Cammas, Pratap Singhasivanon, Nicholas J. White, François Nosten Pharmacokinetics of amodiaquine and desethylamodiaquine in pregnant and postpartum women with Plasmodium vivax malaria. Antimicrobial Agents and Chemotherapy. Vol.55, No.9 (2011), 4338-4342. doi:10.1128/AAC.00154-11 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/12370
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Pharmacokinetics of amodiaquine and desethylamodiaquine in pregnant and postpartum women with Plasmodium vivax malaria
Abstract
In order to study the pharmacokinetic properties of amodiaquine and desethylamodiaquine during pregnancy, 24 pregnant women in the second and third trimesters of pregnancy and with Plasmodium vivax malaria were treated with amodiaquine (10 mg/kg of body weight/day) for 3 days. The same women were studied again at 3 months postpartum. Plasma was analyzed for amodiaquine and desethylamodiaquine by use of a liquid chromatography-tandem mass spectrometry method. Individual concentration-time data were evaluated using noncompartmental analysis. There were no clinically relevant differences in the pharmacokinetics of amodiaquine and desethylamodiaquine between pregnant (n = 24) and postpartum (n = 18) women. The results suggest that the current amodiaquine dosing regimen is adequate for the treatment of P. vivax infections during pregnancy. Copyright © 2011, American Society for Microbiology. All Rights Reserved.